Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Impact of Inhaled Corticosteroids on Acute Asthma Hospitalization in Sweden

1978 To 1991

Bibliographic Data

ID9103426
AuthorsUlf-Göran Gerdtham (0000-0002-0647-7817, Stockholm School of Economics, corresponding author), Ulf-G Gerdtham, PETER HERTZMAN, Berth Jönsson (0000-0002-0051-7785, Stockholm School of Economics, corresponding author), Bengt Jönsson, G Boman (0009-0005-2149-9175)
Year1996
Volume34
Issue12
Pages1188-1198
Publication date1996-12-01
Open AccessNo
TypeARTICLE
VenueMedical Care (JOURNAL)
Journal identifiersISSN: 0025-7079 • E-ISSN: 1537-1948
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/00005650-199612000-00004
PMID8962585
OpenAlexW2316346418
LanguageEN
References cited17

OBJECTIVES: In clinical studies, it has been found that treating asthmatic patients with inhaled corticosteroids can reduce the need for in-patient care. The purpose of this study was to determine if such a relationship could be observed in available health-care statistics in Sweden and, if such a relationship could be established, what health economic consequences it implied. METHODS: A retrospective study was conducted using regional data on acute hospitalization-ie, number of bed-days in acute somatic in-patient care clinics-and sales of anti-asthmatic drugs from 14 health-care administrative regions, covering 6 million people (71% of the Swedish population) between 1978 and 1991. The data were analyzed in multiple regression analyses where time- and cross-section data were pooled. The variation in bed-days was explained by three variables: (1) the sales of inhaled corticosteroids, (2) the total number of bed-days within acute somatic in-patient care, and (3) the sales of inhaled bronchodilators, which were used as a proxy variable for asthma prevalence. RESULTS: The total number of bed-days due to asthma in the 14 county councils did not show any upward or downward trend between 1978 and 1985. However, after 1985, there was a significant downward trend despite an increase in estimated asthma prevalence. Increased sales of inhaled corticosteroids were significantly correlated (P < 0.01) with a reduction in bed-days due to asthma. The model used indicated that an increase in sales of inhaled corticosteroids by 1 defined daily dose (DDD) per day and 1,000 inhabitants gave, on average over the study period, a reduction of 1.5 bed-days for asthma in acute in-patient care per 1,000 inhabitants. CONCLUSIONS: Clinical trial findings that treating asthmatic patients with inhaled corticosteroids improves asthma control and reduces the need for hospitalization, seem to be realized in clinical practice. The increased costs of inhaled corticosteroids to the health-care system were more than offset by a reduction in the costs for acute somatic hospital care

Acute care · Anesthesia · Asthma · Environmental health · Health care · Inhalation · Inhaled corticosteroids · Population · Proxy (statistics) · Allergic Rhinitis and Sensitization · Asthma and respiratory diseases · Delphi Technique in Research · Demography · Emergency Medicine · Internal Medicine · Medicine · Pediatrics

Highly citedNo

Tools

Open DOI
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae